Another study is reinforcing the importance of CT lung cancer screening. Published in Cancer, this real-world research examined the screening’s impact on military veterans, revealing significant benefits like more early-stage diagnoses and lower all-cause mortality.
The Uptake Challenge
Since the USPSTF endorsed CT lung screening in 2013 for high-risk individuals, primarily those with smoking histories, its adoption has been less than satisfactory. Studies indicate uptake rates are below 10%, although targeted interventions have shown promise in improving these numbers.
The Veterans Health Administration Study
Researchers from the Veterans Health Administration analyzed data from their low-dose CT lung cancer screening program, covering veterans from 2011 to 2018. Given that veterans have higher smoking rates, they experience lung cancer at rates 76% higher than the general population. The study tracked outcomes for 2,200 veterans who underwent screening before a lung cancer diagnosis and compared them to veterans who were diagnosed without prior screening.
Key Findings
- Higher Stage I Diagnosis Rates: 52% vs. 27%
- Lower Stage IV Diagnosis Rates: 11% vs. 32%
- Lower Cancer Mortality Rates: 41% vs. 70%
- Lower All-Cause Mortality Rates: 50% vs. 72%
The substantial reduction in all-cause mortality is particularly noteworthy, as most cancer screening tests mainly demonstrate a decrease in cancer-specific deaths rather than all-cause mortality. The study also highlights the benefits of offering lung screening within a large, integrated healthcare system, which can efficiently track at-risk individuals and ensure they receive necessary screenings.
The Takeaway
Among the numerous positive studies on CT lung cancer screening published this year, this one stands out. It shows that even with low screening uptake, significant benefits can be achieved with the right approach.
For more information, you can read article here
